Foreign private-equity rush fuels Indian hospital boom, sparking cost-battle with insurers

In the last half-decade, major private-equity houses—including Blackstone, KKR, TPG, General Atlantic and Temasek—have invested about $10 billion in Indian hospital groups, accelerating growth in high-profit areas such as cardiac and cancer care. The capital has funded new facilities, advanced technology and a wave of mergers, yet PE-owned chains still hold under 5 % of total beds. A parliamentary committee flagged the “unchecked influx of foreign capital” as a driver of higher costs and recommended tighter investment rules and price caps.

Insurers argue that these operators push expensive procedures and inflate bills, while hospital executives cite slow insurer payments and inadequate rates as margin squeezes. A recent case saw a Mumbai consultant pay out-of-pocket for the robotic component of surgery after her insurer declined coverage. Regulators have introduced new cashless-treatment rules, but experts doubt regulation alone can curb rising healthcare expenses, and investors warn that stricter rules could deter future funding.